person
as of 2026-07-01Donald C. Goff, M.D.
Donald C Goff, M.D.Donald Goff, M.D.
at a glance
Roles: Principal Investigator
KOL signal score 5
0 publications · 0 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Massachusetts General Hospital
Roles
Principal Investigator
KOL signal
5
Publications
0 (0 high-value)
Trial investigator
yes
Trials led
7
High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms
NCT00403546Phase 3Completed
D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
NCT00963924—Completed
Folate Supplementation in Schizophrenia
NCT00249288Phase 4Completed
A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia
NCT00455715Phase 4Completed
Risperidone Augmentation in Patients With Schizophrenia
NCT00289861Phase 4Completed
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia
NCT00455702Phase 4Completed
Once Weekly D-cycloserine for Schizophrenia
NCT00964041Phase 4Withdrawn
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR